Pharma News

NVIDIA announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases. The work supports Novo Nordisk’s agreement with DCAI to use the Gefion sovereign AI supercomputer.

Pharmazz, Inc. a late-stage biopharmaceutical company developing innovative therapies for unmet medical needs in critical care and neurology, has announced a 25 million USD equity investment from Sun Pharmaceutical Industries Limited

Telix Pharmaceuticals Limited announces that its next-generation PSMA-PET imaging1 agent for prostate cancer, Gozellix (kit for the preparation of gallium-68 , is now commercially available nationally in the United States (U.S.).

Biocon Foundation, the Corporate Social Responsibility arm of Biocon Group in collaboration with The Bengaluru Science and Technology (BeST) Cluster, and National Centre for Biological Sciences (NCBS) today announced the launch of first-of-its-kind program BioWISE – Women in STEM Empowered, aimed at disadvantaged science students from tier 2 and 3 universities across Karnataka, to build a career in life sciences.

Zydus Lifesciences has received the Establishment Inspection Report from the United States Food and Drug Administration for its Active Pharmaceutical Ingredient manufacturing facility located at Dabhasa, near Vadodara, Gujarat.

A new study published in the journal Diabetes, Obesity and Metabolism has found that sodium-glucose co-transporter-2 (SGLT2) inhibitors are associated with a reduced incidence of atrial fibrillation in patients with type 2 diabetes mellitus.

The mammalian liver has an extraordinary regenerative capacity, capable of fully restoring its mass and function after injury or partial resection. A study led by researchers at the University of Barcelona has identified the DNA regions that activate the regeneration of this organ.

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in NPJ Vaccines.